SCHEMBL25565751

SCHEMBL25565751

CC(C)OCCCN(C)CCCOC(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.38
CHRM2 P08172 1/20 0.35
PIK3CD O00329 1/20 0.34
ALDH1A1 P00352 3/20 0.34
SLC6A2 P23975 3/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 3/20 0.33
SIGMAR1 Q99720 1/20 0.33
TP53 P04637 1/20 0.31
PKM P14618 1/20 0.31
CA12 O43570 1/20 0.30
CA2 P00918 1/20 0.30
CA3 P07451 1/20 0.30
CA4 P22748 1/20 0.30
CA6 P23280 1/20 0.30
CA5A P35218 1/20 0.30
CA7 P43166 1/20 0.30
CA9 Q16790 1/20 0.30
CA14 Q9ULX7 1/20 0.30
CA5B Q9Y2D0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25565770 0.95 CHRM2 (0.37) KDM4ECHRM2PIK3CDALDH1A1SLC6A2
SCHEMBL25565768 0.92 CHRM2 (0.39) KDM4ECHRM2PIK3CDALDH1A1SLC6A2
SCHEMBL25075497 0.91 PIK3CD (0.43) KDM4ECHRM2PIK3CDALDH1A1TP53
SCHEMBL25963452 0.91 HTR1D (0.36) KDM4ECHRM2PIK3CDALDH1A1SIGMAR1
SCHEMBL15511370 0.88 KDM4E (0.35) KDM4EPIK3CDALDH1A1
SCHEMBL20970411 0.86 KDM4E (0.34) KDM4EPIK3CDALDH1A1
SCHEMBL25569588 0.85 KDM4E (0.32) KDM4ECHRM2
SCHEMBL19502501 0.85 SIGMAR1 (0.38) KDM4EALDH1A1SIGMAR1TP53PKM
SCHEMBL2621579 0.84 ALDH1A1 (0.43) KDM4EALDH1A1SMN1; SMN2
SCHEMBL18512355 0.84 SIGMAR1 (0.37) KDM4ECHRM2ALDH1A1SIGMAR1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11859201-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TIBA BIOTECH LLC (US) 2024-01-02 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY TIBA BIOTECH LLC (US) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149562-A1 CARRIERS FOR EFFICIENT NUCLEIC ACID DELIVERY POLN, TLR9, TSG101 KDM4E 4832/4885CHRM2 4667/4885PIK3CD 3816/4885
US-11859201-B2 Nanoparticle compositions containing sugar functionalized nucleic acid carriers TLR9, TLR3, TSG101 KDM4E 4820/4885CHRM2 4752/4885PIK3CD 2183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.